PVMCV
Polaris Venture Management Co V Portfolio holdings
AUM
$14.1M
This Quarter Return
-9.98%
1 Year Return
+121.41%
3 Year Return
+278.88%
5 Year Return
+1,121.38%
10 Year Return
–
AUM
$113M
AUM Growth
+$113M
(-2.5%)
Cap. Flow
+$21.9M
Cap. Flow
% of AUM
19.29%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
–
Reduced
4
Closed
–
Top Buys
| 1 |
X4 Pharmaceuticals
XFOR
|
$23.8M |
Top Sells
| 1 |
Pulmatrix
PULM
|
$1.14M |
| 2 |
KALA BIO
KALA
|
$616K |
| 3 |
Cartesian Therapeutics
RNAC
|
$203K |
| 4 |
Dare Bioscience
DARE
|
$5.43K |
Sector Composition
| 1 | Healthcare | 93.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
KALA BIO
KALA
$78.8M
| $34.3M | 30.28% | 1,857,582 -33,331 | -2% | -$616K |
|
|
2
X4 Pharmaceuticals
XFOR
$84.2M
| $23.8M | 21.03% | +1,868,957 | New | +$23.8M |
|
|
3
Cartesian Therapeutics
RNAC
$261M
| $15.8M | 13.9% | 1,606,813 -20,714 | -1% | -$203K |
|
4
Fate Therapeutics
FATE
$120M
| $15.1M | 13.32% | 2,473,186 | – | – |
|
|
TTOO
5
DELISTED
T2 Biosystems, Inc
TTOO
| $7.73M | 6.81% | 1,875,524 | – | – |
|
|
ATYR
6
aTyr Pharma
ATYR
$527M
| $6.4M | 5.64% | 1,827,992 | – | – |
|
|
7
Pulmatrix
PULM
$18M
| $3.94M | 3.48% | 2,796,407 -811,589 | -22% | -$1.14M |
|
|
TRVN
8
DELISTED
Trevena, Inc.
TRVN
| $3.29M | 2.9% | 2,053,540 | – | – |
|
|
GNCA
9
DELISTED
Genocea Biosciences, Inc.
GNCA
| $2.28M | 2.01% | 1,968,606 | – | – |
|
|
10
Dare Bioscience
DARE
$27.2M
| $706K | 0.62% | 326,243 -2,509 | -0.8% | -$5.43K |
|